authors
- Navani, V
- Ernst, MS
- Takemura, K
- Pal, SK
- Powles, TB
- Donskov, F
- Wells, JC
- Kollmannsberger, CK
- Beuselinck, B
- Alva, AS
- Weickhardt, AJ
- Lalani, Aly-Khan
- Ernst, DS
- Agarwal, N
- Choueiri, TK
- Heng, DYC
The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
Conferences
- Overview
- Additional Document Info
- View All
Overview
publication date
- September 10, 2022
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal
presented at event
- ESMO Congress Conference